Leukemia m1 can be cured by chemotherapy and hematopoietic stem cell transplantation combined treatment for many patients, and its prognosis is related to age, physical status, number of cells and many other factors. 1. The full name of leukemia m1 is acute granulocytic leukemia undifferentiated, and acute leukemia is curable. Without treatment, the median survival is only about 3 months, and there is always the risk of a life-threatening condition. Given a combination of chemotherapy and hematopoietic stem cell transplantation, many patients can achieve long-term survival. 2. The prognosis for patients with leukemia M1 is related to age, physical status, and the number of leukemia cells. For patients with poor prognosis, allogeneic hematopoietic stem cell transplantation can be done after remission. Those with an intermediate prognosis can be given an autologous hematopoietic stem cell transplant after remission and conversion of tiny residual lesions. Once the diagnosis of leukemia m1 is confirmed, standardized treatment should be carried out in a timely manner.